SLB
55
2
BF.B
33
2
CA
38
6
DD
63
3
URBN
56
14
HBI
59
4
NRG
49
-3
BMY
60
2
RIG
60
2
XRX
44
3
CMG
72
5
LH
43
-2
NVDA
56
-4
ILMN
42
5
VZ
50
3
GE
67
2
HOG
35
2
SWK
64
5
PG
56
5
BWA
48
2
SLB
55
2
BF.B
33
2
CA
38
6
DD
63
3
URBN
56
14
HBI
59
4
NRG
49
-3
BMY
60
2
RIG
60
2
XRX
44
3
CMG
72
5
LH
43
-2
NVDA
56
-4
ILMN
42
5
VZ
50
3
GE
67
2
HOG
35
2
SWK
64
5
PG
56
5
BWA
48
2
Financhill
Back

Immunovant Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57

IMVT
Immunovant

Last Price:
26.88
Seasonality Move:
2.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Immunovant Stock Forecast

  • Over the next 52 weeks, Immunovant has on average historically risen by 99.9% based on the past 5 years of stock performance.
  • Immunovant has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Immunovant Stock Undervalued?
    The current Immunovant [IMVT] share price is $26.87. The Score for IMVT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • IMVT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Immunovant Stock Go Up Next Year?

  • Over the next 52 weeks, Immunovant has on average historically risen by 99.9% based on the past 5 years of stock performance.

Immunovant Stock Rating

Buy
57
Immunovant (IMVT) is a Buy

Is Immunovant overpriced?

  • Immunovant has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Immunovant Stock Price History

Is IMVT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMVT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunovant.com

52-Week Data

52-Week High:
45.58
52-Week Low:
24.61

Prediction Charts

Market Cap:
3.94B
Price in USD:
26.87
Volume:
506.15K
Beta:
0.71

Technical Analysis

SMA50:
29.09
SMA100:
29.42
SMA200:
29.92
52-Wk Change:
-17.77%

Stock Predictions

  • Is Immunovant stock public?
    Yes, Immunovant is a publicly traded company.
  • What is the Immunovant stock quote today?
    The Immunovant stock price is 26.87 USD today.
  • How to buy Immunovant stock online?
    You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 29.17 30.32 30.38 28.45
Nov-6 30.54 31.42 32.10 30.54
Nov-7 31.26 29.93 31.66 29.61
Nov-8 29.91 30.63 31.26 29.67
Nov-11 30.76 31.14 31.65 30.63
Nov-12 30.84 29.27 31.18 28.94
Nov-13 29.62 28.93 30.25 28.52
Nov-14 28.80 28.05 28.99 28.01
Nov-15 28.00 26.63 28.04 26.41
Nov-18 26.56 25.51 27.00 25.24
Nov-19 25.19 25.22 25.39 24.61
Nov-20 25.37 26.17 26.22 24.87
Nov-21 26.43 26.54 26.78 25.90
Nov-22 26.66 26.87 27.01 26.58

Immunovant Earnings

Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunovant Forecast Revenue Growth

Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and a decrease next year of $1.15 per share.

* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.